Novavax Covid-19 vaccine found 89.3% effective
New York: US-based biotechnology company Novavax on Friday announced that its Covid-19 vaccine was 89.3 percent effective in preventing Covid-19 in a trial conducted in the UK.
The study assessed efficacy of the vaccine -- NVX-CoV2373 --…